See every side of every news story
Published loading...Updated

Osivax publishes positive results from trial of influenza vaccine candidate - Pharmafile

Summary by pharmafile.com
French biopharma, Osivax, has announced positive results from its phase 2 study, OVX836-004, into OVX836, its broad-spectrum influenza vaccine lead candidate. The results have been published in the journal, Vaccines. In the study, 180 healthy adults aged 18 to 55 years were given either Fluarix Tetra  (hemagglutinin antigen-based inactivated influenza vaccine) with a placebo, Fluarix […] The post Osivax publishes positive results from trial of i…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Tuesday, July 15, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.